Sabby Management, LLC Astrazeneca PLC Transaction History

Sabby Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $17.2 Million - $19.9 Million	-365,000 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$48.52 - $58.02 $10.5 Million - $12.6 Million	217,055 Added 146.71%	365,000 $18.2 Million
Q3 2020 Nov 16, 2020	BUY	$53.07 - $61.1 $6.19 Million - $7.13 Million	116,625 Added 372.37%	147,945 $8.11 Million
Q2 2020 Aug 14, 2020	BUY	$43.1 - $55.31 $1.35 Million - $1.73 Million	31,320 New	31,320 $1.66 Million
Q3 2018 Nov 14, 2018	SELL	$34.76 - $39.72 $2.38 Million - $2.72 Million	-68,464 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$34.55 - $37.05 $2.37 Million - $2.54 Million	68,464 New	68,464 $2.4 Million

1,334

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $218B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Sabby Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sabby Management, LLC with notifications on news.